INNOPEUTICS LTD
Company number 12106982 · Active · London WC2H 9JQ
INNOPEUTICS LTD is an active private limited company (company number 12106982) incorporated on 17 July 2019, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 December 2024, showing net assets of £31k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 32% on the prior period (£23k).
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
Key dates
- Incorporated
- 17 July 2019
- Next accounts due
- 30 September 2026 — 20 days overdue
- Confirmation statement due
- 31 July 2027 — in 284 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 32500
- Manufacture of medical and dental instruments and supplies
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 December 2024
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £31k | — | — | £15k | — | — | 0 |
| 31 December 2023 | £23k | — | — | £16k | — | — | 0 |
- Current ratio
- 3.01 — comfortable
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 74/100 (grade B)
- +10 Positive net assets — Net assets £30,658 at 2024-12-31
- +8 Net assets growing — +32.0% vs prior period
- +8 Comfortable liquidity — Current ratio 3.01
- +8 Established — Incorporated 2019-07-17 (7 years)
- -10 Accounts overdue — Due 2026-09-30
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Mehran Nourani — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 17 July 2019
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (manufacture of basic pharmaceutical products), closest in incorporation date.
- INTERNATIONAL BIOPHARMA LIMITED — London, inc. Jul 2019
- BLUEPRINT MEDICINES (UK) LTD. — London, inc. Jul 2019
- VITABIOTICS DISTRIBUTION LTD — London, inc. Aug 2019
- ECS PHARMA LIMITED — London, inc. Aug 2019
- NR PHARMA LTD — London, inc. Sept 2019
- WORLD PHARMA LIMITED — London, inc. Sept 2019
Reminders for INNOPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.